2Divisson M. Treatment of Alzheimer's Disease: an evaluation of the cholinergic approach[J]. Acta Psychitre Scand Suppl, 1991, 336:47.
3Kwon OS, Chung YB, Kim MH, et al. Pharmacokinetics of propentofylline and the quantitation of its metabolite hydroxypropentofylline in human volunteers[J]. Arch Pharm Res, 1998, 21(6):698.
4Krall WJ, Scramek JJ, Cutler NR. Prospects for pharmacological intervention in Alzheimer's Disease[J]. Ann Pharma, 1999, 33(4):441.
6McGeer PL, McGeer EG. Anti-inflammatory drugs in the fight against Alzheimer's Disease[J]. Ann NY Acad Sci, 1996, 777:213.
7Pieri C, Marra M, Gaspar R. Melatonin protects LDL from oxidation but dose not prevent the apolipoprotein derivatization[J]. Biochem Biophys Res Commun, 1995, 20:159.
8Klafki W, Paganetti PA, Sommer B, et al. Calpain inhibitor I decreases beta A4 secretion from human embryonal kidney cells expressing beta-amyloid precursor protein carrring the APP 670/671 double mutation[J]. Neurosci Lett, 1995, 201(1):29.
